About
Acceptance Rate:
16%
Time from acceptance to publication:
24 days*
Impact Factor (JCR):
3.7
Citescore:
9.3
2023 Total content views:
458,035
2023 Total Altmetric mentions:
1,325
Aims and scope
BMJ Open Diabetes Research & Care is an open access diabetes journal committed to publishing high-quality basic and clinical research articles regarding type 1 and type 2 diabetes and associated symptoms, complications, and treatments. Submissions are subject to rigorous external peer review to ensure the publication of high-quality information.
The online-only format allows for continuous updates and serves as an invaluable resource to the multidisciplinary community of endocrinology, public health/prevention and internal medicine. A rapid review process will also ensure that timely, up-to-date research is available internationally.
BMJ Open Diabetes Research & Care is published by BMJ in partnership with the American Diabetes Association.
Editorial board
For information about BMJ Open Diabetes Research & Care Editor-in-Chief Mandeep Bajaj and his editorial team, please refer to the Editorial Board page.
Ownership
BMJ Open Diabetes Research & Care is owned by BMJ.
Journal information
Publication Model
Open access
Frequency
Continuous
ISSN
2052-4897
Launch Date
2014
Indexed by
Web of Science Core Collection: Science Citation Index Expanded, Emerging Sources Citation Index; MEDLINE (Index Medicus), PubMed Central, Scopus, Embase (Excerpta Medica), DOAJ, Google Scholar
Peer Review Model
Single anonymised; the names of reviewers are hidden from the author
Journal Statistics 2023
Acceptance rate: 16%
Speed
Time to first decision without review: 5 days (median)
Time to first decision with review: 42 days (median)
Time from acceptance to publication: 24 days (median)
Impact
Impact Factor category: Endocrinology & Metabolism
Impact Factor (JCR): 3.7
Impact Factor rank (JCR): 62/186
5 Year Impact Factor: 4
Journal Citation Indicator: 0.93
Eigenfactor Score: 0.0106
Citescore: 9.3
Citescore rank: 35/244
SciMago Journal Rank (SJR): 1.479
Reach
2023 total content views: 458,035
2023 total Altmetric mentions: 1,325
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure.
How we get these metrics
Advertising
Online advertising – USA and Canada only
Jim Cunningham
jcunningham@cunnasso.com
Tel: +1 201.767.4170
Fax: +1 201.767.8065
Online advertising – All countries except USA and Canada
Mark Clifford
Email: mclifford@bmj.com
Information about advertising
Affiliations
Founded in 1940, the American Diabetes Association funds research to prevent, cure and manage diabetes, and among its many activities delivers services to hundreds of communicates and advocates on behalf of those affected by the disease. www.diabetes.org
Dryad is an international repository of data underlying peer-reviewed articles in the basic and applied biosciences. Dryad enables scientists to validate published findings, explore new analysis methodologies, repurpose data for research questions unanticipated by the original authors, and perform synthetic studies. BMJ has been working with Dryad since 2010.
The BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. BMJ is a sponsor of its activities.
The mission of OASPA is to support and represent the interests of open access journal publishers globally in all scientific, technical, and scholarly disciplines. BMJ has been a member since 2009.
All BMJ Open Diabetes Research & Care articles are licensed using either Creative Commons Attribution (CC BY) or Attribution Non-Commercial (CC BY-NC) licence. These licenses let others distribute, remix, tweak and build upon your work. See our open access page for more details.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results.